Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children

BACKGROUND: The peak season of respiratory syncytial virus (RSV) infections in warmer climates may extend beyond the typical five-month RSV season of temperate regions. Additional monthly doses of palivizumab may be necessary in warmer regions to protect children at high risk for serious infection b...

Descripción completa

Detalles Bibliográficos
Autores principales: al-Alaiyan, Saleh, Pollack, Paul, Notario, Gerard F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2015
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353192/
https://www.ncbi.nlm.nih.gov/pubmed/25767550
http://dx.doi.org/10.7573/dic.212270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353192/
https://www.ncbi.nlm.nih.gov/pubmed/25767550
http://dx.doi.org/10.7573/dic.212270

Ejemplares similares